Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Philadelphia-Negative ALL”

100 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 100 results

Not applicableStudy completedNCT01816256
What this trial is testing

Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasms (MPN)Polycythemia Vera (PV)Essential Thrombocythemia (ET)+1 more
University Health Network, Toronto 102
Early research (Phase 1)Study completedNCT00351975
What this trial is testing

Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases

Who this might be right for
Accelerated Phase of DiseaseAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+17 more
National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)Study completedNCT00006475
What this trial is testing

STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis

Who this might be right for
Leukemia
Novartis
Testing effectiveness (Phase 2)UnknownNCT02660762
What this trial is testing

Modified MRCUKALLⅫ/ECOGE2993 Regimen for ALL

Who this might be right for
Leukaemia,Lymphoblastic
Sun Yat-sen University 100
Testing effectiveness (Phase 2)Looking for participantsNCT05660473
What this trial is testing

Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 100
Testing effectiveness (Phase 2)Ended earlyNCT00003561
What this trial is testing

Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 48
Testing effectiveness (Phase 2)Study completedNCT00006053
What this trial is testing

STI571 in Treating Patients With Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa

Who this might be right for
Leukemia
Novartis
Large-scale testing (Phase 3)Study completedNCT01387763
What this trial is testing

Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms

Who this might be right for
Polycythemia VeraEssential ThrombocythemiaPrimary Myelofibrosis
Thomas Stauffer Larsen 202
Not applicableStudy completedNCT02010931
What this trial is testing

Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients

Who this might be right for
Acute Lymphoblastic Leukemia
Amgen 310
Testing effectiveness (Phase 2)Ended earlyNCT03523429
What this trial is testing

PETHEMA-BLIN-01/PET069014 (BLIN-01)

Who this might be right for
Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL
PETHEMA Foundation 11
Large-scale testing (Phase 3)UnknownNCT00025402
What this trial is testing

Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
III. Medizinische Klinik Mannheim 1,000
Testing effectiveness (Phase 2)Study completedNCT03249870
What this trial is testing

Study of Inotuzumab Ozogamicin Combined to Chemotherapy in Older Patients With Philadelphia Chromosome-negative CD22+ B-cell Precursor ALL

Who this might be right for
Acute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP)
Versailles Hospital 131
Early research (Phase 1)Study completedNCT01132573
What this trial is testing

Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic Leukemia

Who this might be right for
Acute Leukemias of Ambiguous LineagePhiladelphia Chromosome Negative Adult Precursor Acute Lymphoblastic LeukemiaRecurrent Adult Acute Lymphoblastic Leukemia+1 more
National Cancer Institute (NCI) 27
Not applicableStudy completedNCT06159816
What this trial is testing

PREVALENCE STUDY OF PNH CLONES IN PATIENTS WITH NEOPLASIES

Who this might be right for
Myeloproliferative Neoplasm
AUSL Romagna Rimini 300
Testing effectiveness (Phase 2)Ended earlyNCT04216563
What this trial is testing

ABL001 for the Treatment of Chronic Myeloid Leukemia in Patients Who Are on Therapy With Tyrosine Kinase Inhibitor

Who this might be right for
Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT00011934
What this trial is testing

Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Large-scale testing (Phase 3)Ended earlyNCT02013167
What this trial is testing

Blinatumomab Versus Standard of Care Chemotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Amgen 405
Not applicableUnknownNCT02617004
What this trial is testing

Multicenter Trial Treatment of Philadelphia Chromosome Negative B-cell Acute Lymphoblastic Leukemia of Young Adults

Who this might be right for
Philadelphia Chromosome Negative Adult B-cell Acute Lymphoblastic Leukemia
Assistance Publique - Hôpitaux de Paris 500
Testing effectiveness (Phase 2)Study completedNCT03367299
What this trial is testing

Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoid LeukemiaPhiladelphia Chromosome-Negative B-Cell Precursor
Gruppo Italiano Malattie EMatologiche dell'Adulto 149
Testing effectiveness (Phase 2)Active Not RecruitingNCT07199855
What this trial is testing

Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk Ph Negative Acute B-cell Lymphoblastic Leukemia

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia, Adult
Zhejiang University 24
Next Page